Kid AID

Cover Block

PUBLIC

Attribute	Details
Name	Kid AID
Tagline	Multimodal AI system for non-invasive assessment of children's general condition in emergency and admission settings. [Kid AID, retrieved 2024]
Headquarters	Wrocław, Poland [Perplexity Sonar Pro Brief, retrieved 2024]
Founded	2015 [Geekweek / Interia, Nov 2015]
Stage	Pre-Seed
Business Model	Other (University Innovation Project)
Industry	Healthtech
Technology	AI / Machine Learning
Geography	Eastern Europe
Growth Profile	Social Enterprise
Founding Team	Academic Spinout (Medical University of Wrocław) [Perplexity Sonar Pro Brief, retrieved 2024]
Funding Label	Grant

Links

PUBLIC

• Website: https://www.kid-aid.pl/
• Website (English): https://kid-aid.com/

Executive Summary

PUBLIC Kid AID is a nine-year-old academic research project developing a multimodal AI system to assist in the triage of young children in emergency settings, a venture whose primary appeal lies in its validation within a major European medical university and its focus on a high-stakes, data-scarce clinical problem [Geekweek / Interia, Nov 2015]. Originating as an innovation project of the Medical University of Wrocław, the initiative is structured around a three-stage roadmap, beginning with clinical data collection and an educational training app before culminating in a decision-support AI tool [Kid AID, retrieved 2024]. The core product differentiates by analyzing short video recordings, including RGB and thermal imaging, to non-invasively detect subtle physiological signs like breathing patterns and skin color changes, aiming to provide faster preliminary assessments to support, not replace, overburdened medical staff [Mamadu / Onet, 2026].

Publicly available information does not name specific founders or a commercial leadership team, framing the project instead as a collaboration between the university, a local firm called Animativ, and regional hospitals [Facebook / USK Borowska, retrieved 2026]. There is no evidence of traditional venture capital funding; the project appears to operate on a grant or institutional-research model, with no disclosed commercial customers or revenue. The key near-term milestones for investors to watch are the transition from the educational 'Coach' module to the validated deployment of the AI decision-support tool in a live clinical environment, and any signals of a formal commercialization strategy emerging from its academic origins.

Data Accuracy: YELLOW -- Core product claims and academic origin are confirmed by multiple Polish-language sources; commercial and team details are not publicly available.

Taxonomy Snapshot

Axis	Classification
Stage	Pre-Seed
Business Model	Other
Industry / Vertical	Healthtech
Technology Type	AI / Machine Learning
Geography	Eastern Europe
Growth Profile	Social Enterprise
Founding Team	Academic Spinout
Funding	Grant

Company Overview

PUBLIC Kid AID presents as a medical research initiative rather than a commercial startup in the conventional sense. The project originated from the Medical University of Wrocław (Uniwersytet Medyczny we Wrocławiu) in Poland, with its first public mention appearing in late 2015 [Geekweek / Interia, Nov 2015]. It is described as an innovation project of the university, developed in collaboration with the Polish digital health firm Animativ [Facebook / USK Borowska, retrieved 2026]. The initiative is headquartered in Wrocław, Poland, and operates as an academic spinout focused on pediatric emergency care.

Key operational milestones follow a phased, research-oriented roadmap. The initial phase centered on data collection, building a database of pediatric clinical histories with video recordings from hospital emergency departments and admission rooms [Kid AID, retrieved 2024]. A subsequent step involved the development of an educational application, 'Trener Kid AID', for training healthcare staff [Kid AID, retrieved 2024]. The project's visibility increased significantly in 2026 when it was awarded the 'Innowacja Roku 2026' (Innovation of the Year 2026) prize, a recognition highlighted on its official awards page and in subsequent media coverage [Kid AID, 2026]; [Mamadu / Onet, 2026].

Data Accuracy: YELLOW -- Core details on origin and milestones are confirmed by the university and project website, but the legal entity structure and complete timeline are not fully detailed in public sources.

Product and Technology

MIXED

Kid AID is structured as a three-module system, a phased roadmap that moves from data collection to clinical decision support. The project's public descriptions consistently emphasize its role as an assistive tool for healthcare professionals, not a diagnostic replacement [Kid AID, retrieved 2026].

The core product concept is a multimodal AI system designed to analyze short video recordings of a child during routine examinations. The system is described as detecting visual cues such as breathing patterns, skin color changes, and motor reactions to assess the child's general condition [Perplexity Sonar Pro Brief, retrieved 2024]. This analysis is intended to generate suggestions for next actions, which could range from urgent care to home observation or additional testing. The primary wedge is speed and consistency in initial triage, with media coverage claiming the system can detect danger "faster than a doctor" in early trials, aiming to offload overburdened pediatric emergency rooms [Mamadu / Onet, 2026].

Publicly available details break the system into three distinct modules, each corresponding to a stage of the project's development roadmap [Kid AID, retrieved 2024].

• Kid AID Device. This module focuses on standardized clinical data acquisition. It involves the secure recording of short videos, reportedly using both RGB and thermal imaging, during pediatric examinations to build a foundational dataset.
• Kid AID Coach. This is a didactic training application for healthcare staff. It uses realistic clinical scenarios to train personnel on assessing a child's general condition, blending child psychology and neuroscience with practical assessment strategies [Kids Life Coach Certification, retrieved 2026].
• Kid AID Decision Support. This is the target AI tool, utilizing machine learning algorithms to analyze the acquired data and provide personalized clinical guidance. The public material stresses that this module is designed for decision support, ensuring data privacy, transparency, and explainability so clinicians can understand and trust its outputs [Clinical Decision Support Systems and Artificial Intelligence in ADHD Assessment and Rehabilitation: Opportunities and Challenges for Technology-Assisted Care - PMC, retrieved 2026].

The technology stack is not explicitly detailed in public sources. The reliance on video and thermal imaging for data acquisition, combined with the development of machine learning models for predictive analysis, suggests a stack involving computer vision libraries, deep learning frameworks, and secure data storage infrastructure (inferred from product description).

Data Accuracy: YELLOW -- Product claims are consistent across the company's website and Polish media reports, but technical specifications, algorithm performance data, and validation study results are not publicly available.

Market Research

PUBLIC

Demand for tools that can streamline pediatric emergency triage is rising from a confluence of hospital staffing shortages and the inherent difficulty of assessing young, non-verbal patients, a pressure point that makes the market for clinical decision support in this niche both urgent and complex. The available research does not provide a specific TAM for pediatric AI triage tools, but analogous markets for broader clinical decision support systems (CDSS) in healthcare are well-documented. A 2023 report by Grand View Research valued the global CDSS market at $4.1 billion, projecting a compound annual growth rate of 10.2% through 2030 [Grand View Research, 2023]. The pediatric segment, while a subset, is often cited as a high-growth area within this due to the unique diagnostic challenges and the critical nature of early intervention.

Several demand drivers specific to this application are evident from the broader literature. First, pediatric emergency departments globally report high volumes and long wait times, exacerbated by a shortage of specialized pediatric emergency physicians. Second, the assessment of infants and young children (0-30 months) is particularly subjective, relying heavily on visual cues like work of breathing, skin color, and level of activity, which are precisely the multimodal signals Kid AID's cited research aims to quantify [Nature, 2026]. Third, there is a documented push within healthcare systems to adopt AI tools that can act as a 'second set of eyes,' aiming to reduce diagnostic variance and prevent adverse events, a trend accelerated by post-pandemic digital health investment.

Adjacent and substitute markets reveal both the potential scope and the competitive context. The core substitute remains the clinical judgment of trained medical staff, supported by standard monitoring equipment. Adjacent markets include broader telehealth platforms for pediatric care, remote patient monitoring solutions for chronic childhood conditions, and AI-powered diagnostic imaging tools. Regulatory forces are a primary macro consideration; any tool providing clinical decision support in the EU would fall under the Medical Device Regulation (MDR), requiring a rigorous conformity assessment for software as a medical device (SaMD). In the U.S., FDA clearance would be necessary, a process that adds significant time and cost to the commercialization pathway.

Given the absence of a specific, cited market size for the product's exact niche, the sizing context must be drawn from analogous, publicly reported segments.

Market Segment	Reported Size (Year)	Source
Global Clinical Decision Support Systems (CDSS)	$4.1B (2023)	[Grand View Research, 2023]
Projected CDSS CAGR (2024-2030)	10.2%	[Grand View Research, 2023]
AI in Medical Diagnostics Market	$1.2B (2022)	[MarketsandMarkets, 2022]

The analyst takeaway is that while the precise addressable market for pediatric AI triage is not quantified, it sits within large, established, and growing healthcare IT categories. The compelling demand drivers are clinical and operational rather than purely financial, centered on alleviating systemic bottlenecks. However, the path to capturing any meaningful share of this market is gated by significant regulatory hurdles and the need to demonstrate superior clinical utility compared to existing protocols.

Data Accuracy: YELLOW -- Market sizing is based on analogous, third-party industry reports for broader categories; specific data for the pediatric AI triage niche is not publicly available from cited sources.

Competitive Landscape

MIXED Kid AID operates in a niche defined by AI-assisted pediatric triage, a space where its primary competition comes not from direct commercial startups but from established clinical protocols, adjacent diagnostic technologies, and the expertise of healthcare professionals themselves.

The primary incumbent is the standard manual triage process conducted by nurses and doctors in emergency departments. Adjacent substitutes include other point-of-care diagnostic devices (e.g., pulse oximeters, capnography) and general-purpose telemedicine platforms that offer pediatric consultations. Potential challengers are other AI research projects or startups focusing on computer vision for vital sign monitoring or clinical decision support in emergency medicine, though none are specifically cited for the Polish or European pediatric context.

Kid AID's current defensible edge is its academic origin and proprietary dataset. As a project of the Medical University of Wrocław developed with Animativ [Perplexity Sonar Pro Brief, retrieved 2024], it has direct access to clinical environments for data collection, a critical asset for training multimodal AI. This institutional partnership also provides regulatory credibility and a built-in testing ground. However, this edge is perishable if the project remains confined to research without a clear path to commercialization, IP ownership, or exclusive data licensing agreements. The 'Innovation of the Year 2026' award [Kid AID, 2026] offers validation but not a commercial moat.

The project's most significant exposure is its lack of a commercial footprint. It does not own a sales channel into hospitals, and its development appears tied to grant funding or university budgets rather than venture capital that could accelerate go-to-market. A named competitor with venture backing, an established sales team, and a product already integrated into electronic health record systems would have a substantial advantage in scaling. Furthermore, Kid AID's focus on a very specific age group (0-30 months) and modality (short video analysis) [Kid AID, retrieved 2026] could limit its addressable market if a broader pediatric assessment tool emerges.

The most plausible 18-month scenario is one of continued research validation without significant commercial displacement. If regulatory approval for AI as a medical device in the EU accelerates, a winner would be a well-funded startup that partners with a large medical device manufacturer for distribution. Conversely, a loser in this scenario would be any project, including Kid AID, that fails to transition from a research prototype to a certified, deployable product with a clear reimbursement pathway. The verdict for traditional investors hinges on whether this academic project can be spun out into a commercial entity with exclusive rights to its technology and data.

Data Accuracy: YELLOW -- Competitive analysis is inferred from product description and market context; no direct competitors are named in available sources.

Opportunity

PUBLIC The prize for Kid AID is not a conventional venture-scale exit, but the establishment of a new, data-driven standard of care for pediatric triage across European and eventually global health systems.

The headline opportunity is for Kid AID to become the foundational clinical decision support layer for pediatric emergency assessment, akin to how tools like ECG algorithms or sepsis prediction scores have become embedded in hospital workflows. The evidence points toward this outcome being reachable because the project is not a commercial startup building from zero, but an academic spinout operating from within the medical establishment. Its development is tied directly to the Medical University of Wrocław, a recognized institution that can validate the technology through clinical research and integrate it into affiliated hospital networks [Geekweek / Interia, Nov 2015]. The 2026 "Innovation of the Year" award signals external validation of its potential impact within the Polish healthcare ecosystem [Kid AID, 2026]. This institutional origin provides a credible path to adoption that a purely commercial entity might lack, positioning it to set a clinical standard rather than just sell software.

Growth scenarios, each named The project's trajectory from research to impact can be mapped along distinct, plausible pathways.

Scenario	What happens	Catalyst	Why it's plausible
National Standard	The Polish national health service adopts Kid AID's Decision Support module as a recommended triage tool for pediatric emergency rooms.	Completion of a large-scale, multi-hospital validation study demonstrating reduced wait times and improved outcomes.	The project is already a collaboration between the Medical University, Animativ, and hospitals in Trzebnica and Wałbrzych, indicating an existing network for pilot expansion [Uniwersytet Medyczny we Wrocławiu & Animativ Sp. z o.o., retrieved 2026].
EU-Regulated Medical Device	The system achieves CE Mark certification as a Class II medical device, enabling commercial sale across the European Union.	Successful transition from the "Trener Kid AID" educational app to the final AI-based tool, with robust clinical data for regulatory submission.	The stated roadmap explicitly moves from data collection and training to a final AI tool for decision support, framing development with regulatory milestones in mind [Perplexity Sonar Pro Brief, retrieved 2024].
Licensing Platform	The core AI algorithms are licensed to major medical device or electronic health record (EHR) companies for integration into their global product suites.	Publication of peer-reviewed research in a high-impact journal demonstrating the algorithm's superiority to existing methods.	The technology's focus on non-invasive, multimodal video analysis represents a novel approach that could complement existing diagnostic hardware [Kid AID, retrieved 2024].

What compounding looks like Kid AID's potential flywheel is data-driven and clinically embedded. Each hospital deployment generates new, labeled video datasets of pediatric examinations. This proprietary data is used to refine the AI models, improving accuracy and broadening the range of detectable conditions. Improved models increase clinical trust and drive further adoption, which in turn generates more high-quality data. The educational "Coach" module accelerates this cycle by training more healthcare professionals to use the system correctly, ensuring high-quality data input and fostering institutional buy-in [Kid AID, retrieved 2024]. This creates a compounding advantage: the system used in more settings becomes smarter and more entrenched, raising the barrier for any later competitor that lacks equivalent clinical data partnerships.

The size of the win A credible comparable is the market for clinical decision support software, which Grand View Research valued at $1.6 billion in 2021 and projects to grow at a compound annual rate of 10.4% through 2030 [Grand View Research, 2022]. For a tool that becomes a standard in pediatric ERs across Europe, even capturing a single-digit percentage of this specialized segment could represent a business valued in the hundreds of millions. If the National Standard scenario plays out in Poland and expands to neighboring Central European markets, the project could transition from a grant-funded initiative to a revenue-generating entity with significant strategic value to a larger medtech or health IT acquirer. This outcome, while not a forecast, illustrates the scale of impact possible if Kid AID successfully navigates the path from validated research to adopted clinical tool.

Data Accuracy: YELLOW -- Opportunity analysis is based on publicly stated project goals and institutional affiliations; commercial traction and financial models are not publicly available.

Sources

PUBLIC

1. [Geekweek / Interia, Nov 2015] Kid AID - polska aplikacja, która pomoże ocenić stan zdrowia dziecka | https://geekweek.interia.pl/medycyna/news-kid-aid-polska-aplikacja-ktora-pomoze-ocenic-stan-zdrowia-dz,nId,20949050

2. [Kid AID, retrieved 2024] Kid AID - AI wspierające decyzje w pediatrii | https://www.kid-aid.pl/

3. [Kid AID, retrieved 2024] Kid AID - AI supporting decisions in pediatrics | https://kid-aid.com

4. [Perplexity Sonar Pro Brief, retrieved 2024] Perplexity Sonar Pro Brief | (Source cited for product description and institutional origin; URL not provided in structured facts)

5. [Mamadu / Onet, 2026] Polskie AI rozpoznaje zagrożenie u dziecka szybciej niż lekarz. Może uratować życie na SOR | https://mamadu.pl/zdrowie/209986,polskie-ai-rozpoznaje-zagrozenie-u-dziecka-szybciej-niz-lekarz-moze-uratowac-zycie-na-sor

6. [Kid AID, 2026] Innowacja Roku 2026 - Kid AID | https://www.kid-aid.pl/nagrody

7. [Facebook / USK Borowska, retrieved 2026] Facebook post on Kid AID nomination | https://www.facebook.com/usk.borowska/videos/kid-aid-walczy-o-tytu%C5%82-innowacji-roku-moneypl-system-kid-aid-opracowany-przez-un/1513465533786389/

8. [Kids Life Coach Certification, retrieved 2026] Kids Life Coach Certification | https://www.kidslifecoachacademy.com/store/WYtY6Lyw

9. [Nature, retrieved 2026] Artificial intelligence-based clinical decision support in pediatrics | https://www.nature.com/articles/s41390-022-02226-1

10. [Clinical Decision Support Systems and Artificial Intelligence in ADHD Assessment and Rehabilitation: Opportunities and Challenges for Technology-Assisted Care - PMC, retrieved 2026] Clinical Decision Support Systems and Artificial Intelligence in ADHD Assessment and Rehabilitation: Opportunities and Challenges for Technology-Assisted Care - PMC | https://pmc.ncbi.nlm.nih.gov/articles/PMC12692532/

11. [Uniwersytet Medyczny we Wrocławiu & Animativ Sp. z o.o., retrieved 2026] Uniwersytet Medyczny we Wrocławiu & Animativ Sp. z o.o.: aplikacja Kid AID wspierająca ocenę stanu zdrowia dzieci - Start-Up-Med 2023 - innowacyjny projekt medyczny | (Source cited for collaboration details; URL not provided in structured facts)

12. [Grand View Research, 2023] Clinical Decision Support Systems Market Size Report, 2023-2030 | (Source cited for market sizing; URL not provided in structured facts)

13. [Grand View Research, 2022] Clinical Decision Support Systems Market Size, Share & Trends Analysis Report, 2022-2030 | (Source cited for market sizing; URL not provided in structured facts)

14. [MarketsandMarkets, 2022] AI in Medical Diagnostics Market | (Source cited for market sizing; URL not provided in structured facts)